HOME >> BIOLOGY >> NEWS
European Science Foundation's Forward Look reaches out beyond the endless frontiers

Forward Look exercise on Nanomedicine. The Forward Look exercise has been considered as an important source of inspiration for the European Commissions Strategic Research Agenda of the European Technology Platform on Nanomedicine and has left impactful marks on the ECs Seventh Framework Programme calls.

Three of the more recent Forward Looks topics are focused on developments and challenges in the natural sciences. These Forward Looks have all included some typical foresight methods, such as scenario building, road mapping, interactive workshops or key word analysis. In the Forward Look Nanomedicine, a SWOT analysis (evaluating the Strengths, Weaknesses, Opportunities and Threats for Europe in an international context) was used to structure the current state of affairs and future developments.

The Forward Looks final reports, as the one on Nanosciences and the Long-term Evolution of Information Technology (NSIT), typically develop science policy recommendations and strategies at the European level. These reports are aware that the Forward Look is part of a broader policy-making process needing coherent and comprehensive recommendations, and their conclusions take into account the opportunities and weaknesses of the current structures and dynamics of the European Research Area. Moreover, the priorities suggested by these reports are more explicit in the sense that they are not just seen as new emerging themes but as frameworks to coordinate the dynamics of these specific fields at an international level.

In the Forward Look Systems Biology a plea is made to create a European road map to develop the Grand Challenge on Systems Biology for Europe.

The current invitation for significant Forward Look topics, pronounced by the ESF in July 2007, is expected to initiate once more foresight exercises at the highest scientific level with European relevance.

Impacts of former and present Forward Looks

'"/>

Contact: Christoph Ettl
cettl@esf.org
33-388-767-154
European Science Foundation
8-Aug-2007


Page: 1 2 3 4 5 6

Related biology news :

1. The UAB heads a European research project on proteases and pathological processes
2. Journalists can register now for ECCO 14 -- the European Cancer Conference
3. Climate changes brews trouble for marine life in European Seas, Marine Board-ESF report says
4. Early Europeans unable to stomach milk
5. European launch of International Polar Year 2007-2008
6. IDIBAPS participates in European Network on antibiotic resistances and hospital infections
7. European approval of HIV drug darunavir will provide a potent new option with Fuzeon
8. European launch of International Polar Year 2007-2008
9. European Federation of Biotechnology and Elsevier announce launch of biotechnology journal
10. Putting a face on the earliest modern Europeans
11. European Union outpaces United States on chemical safety

Post Your Comments:
(Date:4/23/2014)... term for novels and films which focus on the consequences ... how these fictions serve as a mental laboratory that allows ... imagine other living conditions. , "Global warming is much ... is also a cultural phenomenon in which meaning is being ... see. And there are so many of them now that ...
(Date:4/23/2014)... biomedical engineer at the University of Houston (UH) is ... transfusions safer. His work is supported by a $1.8 ... , Blood transfusions save millions of lives every ... Without them, for instance, routine surgeries would become life ... strong evidence that transfusions of red blood cells stored ...
(Date:4/22/2014)... to behave at the dinner tablecut up their food and ... Eating Behaviors , found that when 6-10 year old children ... such as drumsticks, whole apples, or corn on the cob ... cut. "They were twice as likely to disobey adults ... Professor and Director of the Cornell Food and Brand Lab. ...
Breaking Biology News(10 mins):Fiction prepares us for a world changed by global warming 2Fiction prepares us for a world changed by global warming 3UH biomedical engineer works to make blood transfusions safer 2UH biomedical engineer works to make blood transfusions safer 3Biting vs. chewing 2
(Date:1/14/2014)... Texas , Jan. 14, 2014 The ... and research medicinal plants and therapeutic derivatives thereof ... health professionals, and researchers about the challenges of ... http://photos.prnewswire.com/prnh/20100430/DC95601LOGO ) The Society ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility ... of Product Strategy. In this role, Michelle will work with ... guide in the development of iLab products. Her main goal ... benefit to the scientific community by offering the most advanced, ...
(Date:1/14/2014)... Mass. , Jan. 14, 2014  RXi Pharmaceuticals ... discovering, developing and commercializing innovative therapies addressing major ... that it received the Notice of Allowance from ... its unique self-delivering RNAi compounds (sd-rxRNA®), for the ...
(Date:1/14/2014)... Ontario , Jan. 14, 2014   Kinaxis ®, provider ... SCM ) and sales and operations planning ( S&OP ) ... Biomanufacturing Summit , which will be held at the ... the conference, join Kinaxis customer Elisabeth Kaszas , Director ...
Breaking Biology Technology:World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
Cached News: